RFHE4043PK: A Sub-study to Evaluate the Pharmacokinetics of Rifaximin in Subjects with Severe Hepatic Impairment and Overt Hepatic Encephalopathy

Project: Research project

Project Details

StatusFinished
Effective start/end date5/3/135/3/16

Funding

  • Valeant Pharmaceuticals North America LLC (RFHE4043PK)
  • Salix Pharmaceuticals, Inc. (RFHE4043PK)